No Time to Lose: A Life in Pursuit of Deadly Viruses
Description:
"An invaluable portrait of the evolution of international health in recent decades." ―William Bynum, Wall Street Journal
When Peter Piot was in medical school, a professor warned, “There’s no future in infectious diseases. They’ve all been solved.” Fortunately, Piot ignored him, and the result has been an exceptional, adventure-filled career. In the 1970s, as a young man, Piot was sent to Central Africa as part of a team tasked with identifying a grisly new virus. Crossing into the quarantine zone on the most dangerous missions, he studied local customs to determine how this disease―the Ebola virus―was spreading. Later, Piot found himself in the field again when another mysterious epidemic broke out: AIDS. He traveled throughout Africa, leading the first international AIDS initiatives there. Then, as founder and director of UNAIDS, he negotiated policies with leaders from Fidel Castro to Thabo Mbeki and helped turn the tide of the epidemic. Candid and engrossing, No Time to Lose captures the urgency and excitement of being on the front lines in the fight against today’s deadliest diseases.
16 pages of illustrationsBest prices to buy, sell, or rent ISBN 9780393345513
Frequently Asked Questions about No Time to Lose: A Life in Pursuit of Deadly Viruses
The price for the book starts from $5.97 on Amazon and is available from 51 sellers at the moment.
If you’re interested in selling back the No Time to Lose: A Life in Pursuit of Deadly Viruses book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the No Time to Lose: A Life in Pursuit of Deadly Viruses book, the best buyback offer comes from and is $ for the book in good condition.
The No Time to Lose: A Life in Pursuit of Deadly Viruses book is in very low demand now as the rank for the book is 911,872 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.